27 Russian Regions Enter Generalized Stage of HIV Epidemic
The HIV epidemic in Russia has transitioned into a “generalized stage” across 27 federal subjects, according to the latest data from the Central Research Institute of Epidemiology. The classification indicates that the virus has moved beyond high-risk groups and is now established within the broader population.
Vasily Akimkin, director of the institute under Rospotrebnadzor, confirmed the milestone in late 2026, noting that the epidemic is increasingly characterized by a shift toward older demographics and heterosexual transmission. Under international epidemiological standards, a “generalized stage” is reached when HIV prevalence among pregnant women in a specific region exceeds 1%.
Demographic Shift and Transmission Trends
The profile of the average HIV-positive individual in Russia has changed significantly over the last 15 years. Researchers report that the average age of those infected has risen from 32 to 44, centering the crisis on the 40–50 age bracket. Data indicates that more than 3% of Russian men aged 40 to 50 are now living with HIV.
This “aging” of the epidemic coincides with a change in how the virus spreads. Heterosexual contact is now responsible for approximately two-thirds of all new infections. This transition marks a departure from earlier phases of the Russian epidemic, which were primarily driven by intravenous drug use in concentrated urban centers.
The highest rates of infection remain concentrated in industrial regions. Kemerovo, Irkutsk, and Sverdlovsk are currently the most affected areas, with prevalence rates exceeding 2% of the general population. While total new incidence saw a recorded decrease of 13.4% in 2025, with approximately 45,000 new cases, the total number of people living with the virus continues to grow because new infections still outpace the 30,000 to 34,000 annual deaths among the HIV-positive population.
The Statistical Gap and Medical Challenges
Epidemiological reports highlight a significant discrepancy between laboratory-confirmed cases and the number of patients receiving official medical supervision. Rospotrebnadzor has recorded approximately 1.23 million laboratory-confirmed HIV diagnoses, yet the Ministry of Health registers only about 846,500 patients. This creates a “shadow population” of nearly 400,000 individuals who may not be accessing regular healthcare or antiretroviral therapy.
Treatment efficacy also remains a concern for public health officials. Currently, only about 50% of the total population living with HIV in Russia has achieved viral suppression, a critical metric for preventing further transmission and ensuring patient health.
In addition to community spread, health authorities have identified rare instances of transmission within the medical system. In 2026, two cases of HIV transmission through blood component transfusions were identified—the first such instances recorded in the country in six years. This development follows a noted 15-year peak in hospital-acquired bloodborne infections, including Hepatitis C, within medical facilities reported in 2025.
The dual challenge of a maturing epidemic in the general population and the re-emergence of clinical transmission routes has placed renewed pressure on regional healthcare infrastructures, particularly in the 27 regions where the 1% threshold among pregnant women has been breached.
